• News
  • SAN DIEGO
  • General

Trovagene names new member to its scientific advisory board

San Diego-based Trovagene Inc. (Nasdaq: TROV), a developer of transrenal molecular diagnostics, announced Monday that Dr. Paul Billings has joined the company's scientific advisory board.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments

Trovagene Inc.

Company Website

11055 Flintkote Ave.
San Diego, CA 92121

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
TROV
5.49
  -0.35  
- 5.99%
601,630,000
8.87
2.97

Trovagene Inc. Executive(s):

Antonius Schuh

  • Chief Executive Officer

Stephen Zaniboni

  • Chief Financial Officer
Subscribe Today!